When.com Web Search

  1. Ads

    related to: hiv drug cost chart

Search results

  1. Results From The WOW.Com Content Network
  2. Cost of HIV treatment - Wikipedia

    en.wikipedia.org/wiki/Cost_of_HIV_treatment

    In 2000, the cost for first-line treatment was over $10,000 per patient per year, [1] and nearly two decades later in 2018, the cost has decreased to as low as $75 per patient per year. [5] An advertisement for The Silence = Death Project of ACT UP to bring about HIV treatment reform.

  3. Efavirenz - Wikipedia

    en.wikipedia.org/wiki/Efavirenz

    Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. [1] It is generally recommended for use with other antiretrovirals. [1] It may be used for prevention after a needlestick injury or other potential exposure. [1] It is sold both by itself and in combination as ...

  4. Management of HIV/AIDS - Wikipedia

    en.wikipedia.org/wiki/Management_of_HIV/AIDS

    Management of HIV/AIDS. The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs as a strategy to control HIV infection. [1] There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active ...

  5. After backlash, Blue Cross NC lowers out-of-pocket costs on ...

    www.aol.com/backlash-blue-cross-nc-lowers...

    A 2015 study from the New England Journal of Medicine found that a quarter of insurance companies used discriminatory drug tiering for HIV medications, which cost people with the condition several ...

  6. Insurers must cover injectable HIV prevention drug — unless ...

    www.aol.com/news/insurers-must-cover-injectable...

    A national health task force’s sterling new endorsement of a long-acting injectable medication for use as HIV prevention will require health insurers to begin covering the pricey drug by 2025.

  7. Elvitegravir - Wikipedia

    en.wikipedia.org/wiki/Elvitegravir

    Elvitegravir (EVG) is an integrase inhibitor used to treat HIV infection. It was developed [1] by the pharmaceutical company Gilead Sciences, which licensed EVG from Japan Tobacco in March 2008. [2][3][4] The drug gained approval by the U.S. Food and Drug Administration on August 27, 2012, for use in adult patients starting HIV treatment for ...

  1. Ads

    related to: hiv drug cost chart